Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 12, pp. 2528-2541
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 5, 2020
- Revision received July 15, 2020
- Accepted September 22, 2020
- Published first September 30, 2020.
Article Versions
- Previous version (September 30, 2020 - 07:55).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Branden A. Smeester1,#,
- Garrett M. Draper1,#,
- Nicholas J. Slipek2,
- Alex T. Larsson2,3,4,
- Natalie Stratton1,
- Emily J. Pomeroy1,
- Kelsie L. Becklin1,
- Kenta Yamamoto1,
- Kyle B. Williams1,
- Kanut Laoharawee1,
- Joseph J. Peterson1,
- Juan E. Abrahante5,
- Susan K. Rathe4,
- Lauren J. Mills1,
- Margaret R. Crosby1,
- Wendy A. Hudson6,
- Eric P. Rahrmann7,
- David A. Largaespada1, and
- Branden S. Moriarity1,*
- 1Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
- 2Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota.
- 3Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota.
- 4Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
- 5UMII, University of Minnesota, Minneapolis, Minnesota.
- 6AHCSH Cancer Center, University of Minnesota, Minneapolis, Minnesota.
- 7Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, England.
- ↵*Corresponding Author:
Branden S. Moriarity, University of Minnesota, Minneapolis, MN 55455. Phone: 612-625-2226; E-mail: mori0164{at}umn.edu
↵#B.A. Smeester and G.M. Draper contributed equally to this article.
December 2020
Volume 19, Issue 12
Volume 19, Issue 12
Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
Jump to section
Advertisement